206 related articles for article (PubMed ID: 18307293)
21. 2,4,6-trisubstituted pyrimidines as a new class of selective adenosine A1 receptor antagonists.
Chang LC; Spanjersberg RF; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; van den Hout G; Beukers MW; Brussee J; Ijzerman AP
J Med Chem; 2004 Dec; 47(26):6529-40. PubMed ID: 15588088
[TBL] [Abstract][Full Text] [Related]
22. Potent, selective, and orally active adenosine A2A receptor antagonists: arylpiperazine derivatives of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines.
Neustadt BR; Hao J; Lindo N; Greenlee WJ; Stamford AW; Tulshian D; Ongini E; Hunter J; Monopoli A; Bertorelli R; Foster C; Arik L; Lachowicz J; Ng K; Feng KI
Bioorg Med Chem Lett; 2007 Mar; 17(5):1376-80. PubMed ID: 17236762
[TBL] [Abstract][Full Text] [Related]
23. Antagonists of the human adenosine A2A receptor. Part 1: Discovery and synthesis of thieno[3,2-d]pyrimidine-4-methanone derivatives.
Gillespie RJ; Adams DR; Bebbington D; Benwell K; Cliffe IA; Dawson CE; Dourish CT; Fletcher A; Gaur S; Giles PR; Jordan AM; Knight AR; Knutsen LJ; Lawrence A; Lerpiniere J; Misra A; Porter RH; Pratt RM; Shepherd R; Upton R; Ward SE; Weiss SM; Williamson DS
Bioorg Med Chem Lett; 2008 May; 18(9):2916-9. PubMed ID: 18406614
[TBL] [Abstract][Full Text] [Related]
24. 6-(2-Furanyl)-9H-purin-2-amine derivatives as A2A adenosine antagonists.
Kiselgof E; Tulshian DB; Arik L; Zhang H; Fawzi A
Bioorg Med Chem Lett; 2005 Apr; 15(8):2119-22. PubMed ID: 15808481
[TBL] [Abstract][Full Text] [Related]
25. Biaryl and heteroaryl derivatives of SCH 58261 as potent and selective adenosine A2A receptor antagonists.
Shah U; Boyle CD; Chackalamannil S; Neustadt BR; Lindo N; Greenlee WJ; Foster C; Arik L; Zhai Y; Ng K; Wang S; Monopoli A; Lachowicz JE
Bioorg Med Chem Lett; 2008 Jul; 18(14):4199-203. PubMed ID: 18562199
[TBL] [Abstract][Full Text] [Related]
26. Identification of non-furan containing A2A antagonists using database mining and molecular similarity approaches.
Richardson CM; Gillespie RJ; Williamson DS; Jordan AM; Fink A; Knight AR; Sellwood DM; Misra A
Bioorg Med Chem Lett; 2006 Dec; 16(23):5993-7. PubMed ID: 16971117
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, biological and modeling studies of 1,3-di-n-propyl-2,4-dioxo-6-methyl-8-(substituted) 1,2,3,4-tetrahydro [1,2,4]-triazolo [3,4-f]-purines as adenosine receptor antagonists.
Pastorin G; Bolcato C; Cacciari B; Kachler S; Klotz KN; Montopoli C; Moro S; Spalluto G
Farmaco; 2005 Aug; 60(8):643-51. PubMed ID: 15961085
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and structure-activity relationships of 1-,3-,8-, and 9-substituted-9-deazaxanthines at the human A2B adenosine receptor.
Carotti A; Cadavid MI; Centeno NB; Esteve C; Loza MI; Martinez A; Nieto R; Raviña E; Sanz F; Segarra V; Sotelo E; Stefanachi A; Vidal B
J Med Chem; 2006 Jan; 49(1):282-99. PubMed ID: 16392813
[TBL] [Abstract][Full Text] [Related]
29. Replacement of amide with bioisosteres led to a new series of potent adenosine A2A receptor antagonists.
Yang Z; Li X; Ma H; Zheng J; Zhen X; Zhang X
Bioorg Med Chem Lett; 2014 Jan; 24(1):152-5. PubMed ID: 24332624
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of N-pyrimidinyl-2-phenoxyacetamides as adenosine A2A receptor antagonists.
Zhang X; Rueter JK; Chen Y; Moorjani M; Lanier MC; Lin E; Gross RS; Tellew JE; Williams JP; Lechner SM; Markison S; Joswig T; Malany S; Santos M; Castro-Palomino JC; Crespo MI; Prat M; Gual S; Díaz JL; Saunders J; Slee DH
Bioorg Med Chem Lett; 2008 Mar; 18(6):1778-83. PubMed ID: 18329269
[TBL] [Abstract][Full Text] [Related]
31. Insight into 2-phenylpyrazolo[1,5-a]pyrimidin-3-yl acetamides as peripheral benzodiazepine receptor ligands: synthesis, biological evaluation and 3D-QSAR investigation.
Selleri S; Gratteri P; Costagli C; Bonaccini C; Costanzo A; Melani F; Guerrini G; Ciciani G; Costa B; Spinetti F; Martini C; Bruni F
Bioorg Med Chem; 2005 Aug; 13(16):4821-34. PubMed ID: 15975799
[TBL] [Abstract][Full Text] [Related]
32. Novel 8-(furan-2-yl)-3-substituted thiazolo [5,4-e][1,2,4] triazolo[1,5-c] pyrimidine-2(3H)-thione derivatives as potential adenosine A(2A) receptor antagonists.
Mishra CB; Barodia SK; Prakash A; Senthil Kumar JB; Luthra PM
Bioorg Med Chem; 2010 Apr; 18(7):2491-500. PubMed ID: 20303771
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and evaluation of fused heterocyclic analogs of SCH 58261 as adenosine A2A receptor antagonists.
Shah U; Lankin CM; Boyle CD; Chackalamannil S; Greenlee WJ; Neustadt BR; Cohen-Williams ME; Higgins GA; Ng K; Varty GB; Zhang H; Lachowicz JE
Bioorg Med Chem Lett; 2008 Jul; 18(14):4204-9. PubMed ID: 18558486
[TBL] [Abstract][Full Text] [Related]
34. Triamino derivatives of triazolotriazine and triazolopyrimidine as adenosine A2a receptor antagonists.
Vu CB; Shields P; Peng B; Kumaravel G; Jin X; Phadke D; Wang J; Engber T; Ayyub E; Petter RC
Bioorg Med Chem Lett; 2004 Oct; 14(19):4835-8. PubMed ID: 15341934
[TBL] [Abstract][Full Text] [Related]
35. 2-Amino-6-furan-2-yl-4-substituted nicotinonitriles as A2A adenosine receptor antagonists.
Mantri M; de Graaf O; van Veldhoven J; Göblyös A; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Link R; de Vries H; Beukers MW; Brussee J; Ijzerman AP
J Med Chem; 2008 Aug; 51(15):4449-55. PubMed ID: 18637670
[TBL] [Abstract][Full Text] [Related]
36. Discovery of N-(1-adamantyl)-2-(4-alkylpiperazin-1-yl)acetamide derivatives as T-type calcium channel (Cav3.2) inhibitors.
Giordanetto F; Knerr L; Selmi N; Llinàs A; Lindqvist A; Wang QD; Ståhlberg P; Thorstensson F; Ullah V; Nilsson K; O'Mahony G; Högberg G; Lindhardt E; Strand A; Duker G
Bioorg Med Chem Lett; 2011 Sep; 21(18):5557-61. PubMed ID: 21782423
[TBL] [Abstract][Full Text] [Related]
37. Discovery of N-(5,6-diarylpyridin-2-yl)amide derivatives as potent and selective A(2B) adenosine receptor antagonists.
Eastwood P; Gonzalez J; Paredes S; Nueda A; Domenech T; Alberti J; Vidal B
Bioorg Med Chem Lett; 2010 Mar; 20(5):1697-700. PubMed ID: 20137946
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and SAR studies of trisubstituted purinones as potent and selective adenosine A2A receptor antagonists.
Shao Y; Cole AG; Brescia MR; Qin LY; Duo J; Stauffer TM; Rokosz LL; McGuinness BF; Henderson I
Bioorg Med Chem Lett; 2009 Mar; 19(5):1399-402. PubMed ID: 19181527
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and preliminary evaluation of new 1- and 3-[1-(2-hydroxy-3-phenoxypropyl)]xanthines from 2-amino-2-oxazolines as potential A1 and A2A adenosine receptor antagonists.
Massip S; Guillon J; Bertarelli D; Bosc JJ; Léger JM; Lacher S; Bontemps C; Dupont T; Müller CE; Jarry C
Bioorg Med Chem; 2006 Apr; 14(8):2697-719. PubMed ID: 16386423
[TBL] [Abstract][Full Text] [Related]
40. Selective adenosine A2a receptor antagonism reduces JNK activation in oligodendrocytes after cerebral ischaemia.
Melani A; Cipriani S; Vannucchi MG; Nosi D; Donati C; Bruni P; Giovannini MG; Pedata F
Brain; 2009 Jun; 132(Pt 6):1480-95. PubMed ID: 19359287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
